INTRODUCTION {#s1}
============

Cholangiocarcinoma (CCA) is an incurable and lethal cancer due to its silent clinical characters, difficulties in early diagnosis, and limited therapeutic approaches. Biopsy and cytology brush biopsy examination is the current gold standard for diagnosis, but it is very difficult to obtain the cells, and the sensitivity is only about 20% \[[@R1]\]. Surgery is an effective means of treatment, but 70% of patients lose the opportunity to surgery because failure of early diagnosis \[[@R2]\]. Therefore, new diagnosis and treatment approaches of CCA are clearly needed.

Tumor-derived exosomes are emerging as a new type of cancer biomarker \[[@R3]\]. Exosomes are 30-100 nm membrane vesicles secreted by a variety of cell types, including tumor cells, it can be generally detected in body fluids such as Serum, urine, saliva, bile, ascites, amniotic fluid, milk, etc \[[@R4]\]. Exosomes are one type of extracellular vesicles (EVs) according to their size and they have been the topic of great interest in recent years in medical research \[[@R5]\]. Exosomes are known to deliver diverse molecules to target cells ranging from mRNAs, non-coding RNAs (ncRNAs) to proteins, which have the diagnostic potential. It is reported that circulating exosomal microRNAs have diagnostic potential for Lung Cancer \[[@R6]\], colon cancer \[[@R7]\], and esophageal squamous cell carcinoma \[[@R8]\]. Combination of serum proteins and microRNAs can increases sensitivity and specificity of pancreatic cancer \[[@R9]\]. Biliary vesicle microRNA-based panel for CCA diagnosis demonstrate a sensitivity of 67% and specificity of 96% \[[@R10]\]. So it is significant to explore and definite the potential functions of the cargos exosomes.

As a subclass of ncRNAs that are present in exosomes, long-ncRNAs (lncRNAs), which are \> 200 nucleotides (nt) in length, regulate gene expression at the epigenetic, transcriptional, and posttranscriptional levels, play important roles in diverse biological processes, including cell proliferation, invasion, differentiation, apoptosis, metastasis and immune response \[[@R11]\]. A recent study showed that lncRNAs microarrays of intrahepatic cholangiocarcinoma (ICC) and paired adjacent noncancerous tissues reveal that lncRNAs are significantly changed \[[@R12]\], however, up to date, changes of lncRNAs in exosomes of CCA remain unclear. In our present study, we used RNA sequencing (RNA-seq) to determine lncRNA repertoires of bile exosome of CCA and benign biliary obstruction patients. In order to explore the function of altered lncRNAs, we also measured the gene expression profile. The enriched pathways, biological process, cellular components and molecular functions were explored using bioinformatics. The relationship between the differentially expressed lncRNAs and genes was also analyzed by constructing the co-expression network.

RESULTS {#s2}
=======

Identification of exosomes in human bile samples {#s2_1}
------------------------------------------------

Exosomes isolated from human bile were imaged by using Transmission electron microscope, TEM. We noted the presence of 30-150 nM of vesicles, consistent with previously reported features of exosomes (Figure [1A](#F1){ref-type="fig"}). Then we employed multiparameter nanoparticle tracking analysis (NTA), and found that the majority of EVs in human bile were between 30 and 150 nM and that the mode of exosome sizes was 72.2 nM (Figure [1B](#F1){ref-type="fig"}), suggesting that EVs isolated are most likely exosomes. The distribution coefficient was 0.436. To further confirm that these spherical structures are exosomes, we assayed for presence of CD63 and CD81, Flow cytometry analysis positive expression of CD63 was 96.4% and CD81 was 91.9%. (Figure [1C](#F1){ref-type="fig"}).

![Identification of exosomes in human bile samples\
**(A)** Typical transmission electron microscopy picture demonstrating the presence of 30-110 nm of spherical structures in human bile. Further characterization demonstrates that these vesicles display exosome characteristics. **(B)** Mode of exosome isolated from human bile was determined to be approximately 72.2 nm (x-axis depicts exosome size and y-axis depicts exosome intensity of each size). **(C)** Presence of typical exosome proteins (CD63 and CD81) in exosome preparations from human bile.](oncotarget-08-69995-g001){#F1}

Differentially expressed lncRNAs {#s2_2}
--------------------------------

A total of 64, 530 transcripts were detected in the current sequencing study, including 30632 transcripts identified as lncRNA. Comparing the mean value of Reads Per Kilobase Million (RPKM) of the CCA group with that of the normal group, 54 transcripts were selected from the 30632 lncRNAs according to the criteria described in the materials and methods section (19 up-regulated and 35 down-regulated). The top 15 up-regulated and 15 down-regulated lncRNAs were listed in Table [1](#T1){ref-type="table"}. Their heat map and volcano plots were displayed in Figures [2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}. Briefly, data normalized by Z score transformation were used in the calculation of significant changes in expression in the Control and CCA group, and the transformed data were used to construct the heatmap. The red signal referred to high relative expression and the blue signal referred to low relative expression.

###### Different expression of lncRNAs

  lncRNA              log2^(Fold\ change)^   *p*-Value   lncRNA              log2^(Fold\ change)^   *p*-Value
  ------------------- ---------------------- ----------- ------------------- ---------------------- -------------------
  ENST00000544663.1   3.571                  0.033       ENST00000571590.1   -3.054                 ENST00000571590.1
  NR_002794           3.220                  0.023       ENST00000548810.1   -2.316                 ENST00000548810.1
  ENST00000516869.1   2.350                  0.000       ENST00000584779.1   -2.272                 ENST00000584779.1
  ENST00000554988.1   2.152                  0.000       ENST00000518675.1   -2.257                 ENST00000518675.1
  ENST00000607140.1   2.080                  0.006       ENST00000521904.1   -2.221                 ENST00000521904.1
  ENST00000454253.1   1.911                  0.031       ENST00000523279.1   -2.145                 ENST00000523279.1
  ENST00000517758.1   1.900                  0.021       ENST00000511793.1   -2.086                 ENST00000511793.1
  ENST00000599110.1   1.807                  0.049       ENST00000531710.1   -2.027                 ENST00000531710.1
  ENST00000580625.1   1.782                  0.000       ENST00000579049.1   -2.007                 ENST00000579049.1
  ENST00000553637.1   1.782                  0.000       ENST00000441146.1   -2.004                 ENST00000441146.1
  ENST00000607393.1   1.677                  0.028       ENST00000452506.1   -1.970                 ENST00000452506.1
  ENST00000588480.1   1.668                  0.026       ENST00000458250.1   -1.955                 ENST00000458250.1
  ENST00000450669.2   1.588                  0.017       ENST00000589623.1   -1.921                 ENST00000589623.1
  ENST00000560221.1   1.482                  0.042       ENST00000565668.2   -1.898                 ENST00000565668.2
  ENST00000561980.1   1.424                  0.046       ENST00000579037.1   -1.804                 ENST00000579037.1

![The heat map and volcano plots\
**(A)** Heat maps showing unsupervised clustering of CCA and controls based on differentially expressed up-regulated lncRNAs (red) and long non-coding genes (blue). **(B)** Volcano plots of all the detected transcripts in both the CCA and biliary obstruction groups. The vertical dotted line delimits up-and down-regulation. Red plots: significant lncRNAs.](oncotarget-08-69995-g002){#F2}

Gene ontology (GO) and **kyoto** encyclopedia of genes and genomes (KEGG) pathway enrichment analysis of the differentially expressed genes {#s2_3}
-------------------------------------------------------------------------------------------------------------------------------------------

A total of 4002 terms in the GO-biological process were involved in current sequencing data. The top 10 biological process terms with the highest *p*-value were listed in Table [2](#T2){ref-type="table"}, and the most significant process was related to "Regulation of autophagy". The top 10 cellular components with the highest *p*-value were shown in Table [3](#T3){ref-type="table"}, and the most significant process was related to "Golgi membrane". The top 10 molecular functions terms were displayed in Table [4](#T4){ref-type="table"}, and the most significant one was "Metal ion binding". GO enrichment for the Cluster analysis of the pathways was shown in Figure [3A](#F3){ref-type="fig"}.

###### Top 10 GO biological processes

  GOBPID       Sample number   Background number   *P* value   Term
  ------------ --------------- ------------------- ----------- ----------------------------------------
  GO:0010506   10              71                  2.085E-04   regulation of autophagy
  GO:0006044   5               16                  2.207E-04   N-acetylglucosamine metabolic process
  GO:0070227   9               62                  2.933E-04   lymphocyte apoptotic process
  GO:0046777   17              188                 4.304E-04   protein autophosphorylation
  GO:0006914   14              141                 5.827E-04   autophagy
  GO:0070232   6               31                  7.679E-04   regulation of T cell apoptotic process
  GO:0016125   13              128                 1.523E-03   sterol metabolic process
  GO:0070231   7               45                  1.701E-03   T cell apoptotic process
  GO:0008203   12              116                 1.876E-03   cholesterol metabolic process
  GO:0006807   290             6306                1.933E-03   nitrogen compound metabolic process

"GOBPID": the ID of biological process in GO database; "Sample number": the number of candidate genes; "Background number": the number of background genes in the pathway; "*P* value": significance level; "Term": pathway function.

###### Top 10 GO cellular components

  GOCCID       Sample number   Background number   *P* value   Term
  ------------ --------------- ------------------- ----------- ------------------------------------------
  GO:0000139   39              574                 0.001       Golgi membrane
  GO:0005622   557             12706               0.004       intracellular
  GO:0044424   549             12559               0.005       intracellular part
  GO:0043231   430             9789                0.009       intracellular membrane-bounded organelle
  GO:0032040   3               10                  0.011       small-subunit processome
  GO:0030684   4               20                  0.011       preribosome
  GO:0005730   40              689                 0.012       nucleolus
  GO:0044431   40              690                 0.012       Golgi apparatus part
  GO:0005737   418             9569                0.013       cytoplasm
  GO:0005905   7               60                  0.013       coated pit

"GOCCID": the ID of cellular component in GO database.

###### Top 10 GO molecular functions

  GOMFID       Sample number   Background number   *P* value   Term
  ------------ --------------- ------------------- ----------- --------------------------------------------
  GO:0046872   217             3944                1.39E-06    metal ion binding
  GO:0043169   220             4015                1.54E-06    cation binding
  GO:0043167   301             5849                3.32E-06    ion binding
  GO:0003824   260             5326                3.18E-04    catalytic activity
  GO:0016740   99              1762                4.43E-04    transferase activity
  GO:0001882   99              1802                8.74E-04    nucleoside binding
  GO:0032550   98              1788                9.9E-04     purine ribonucleoside binding
  GO:0001883   98              1791                1.039E-03   purine nucleoside binding
  GO:0032549   98              1792                1.056E-03   ribonucleoside binding
  GO:0035639   97              1780                1.233E-03   purine ribonucleoside triphosphate binding

"GOMFID": the ID of molecular function in GO database.

![GO and KEGG pathway analysis of the differentially expressed genes\
**(A)** GO enrichment for the cluster analysis of the pathways related to biological processes, cellular components and molecular functions. Horizontal axis denoted the respective -Log10 (p-value) of different pathways and the vertical axis represented the pathway name. Numbers of genes in each cluster are shown in the right black histogra. **(B)** KEGG enrichment for the Cluster analysis of the pathways related to cellular processes, environmental information processing, genetic information processing, human diseases as well as organismal systems. Horizontal axis denoted the respective -Log10 (*p*-value) of different pathways and the vertical axis represented the pathway name. Numbers of genes in each cluster are shown in the right black histogra. **(C)** Detailed network of "P53 signaling pathway". Every node represented the key enzyme or transporter in this pathway. Nodes marked in red were associated with significantly up-regulated genes in the current sequencing data, and the green nodes denoted genes with no significant change.](oncotarget-08-69995-g003){#F3}

KEGG pathway analysis indicated that 240 pathways were involved in the current sequencing data, in which many pathways were related to cellular processes, environmental information processing, genetic information processing, human diseases as well as organismal systems (Figure [3B](#F3){ref-type="fig"}). The most enriched top ten pathway terms with the lowest *p*-value were p53 signaling pathway, apoptosis, lysosome, metabolic pathways, FOXO signaling pathway, mucin type O-Glycan biosynthesis, amino sugar and nucleotide sugar metabolism, endocytosis, sulfur metabolism, tryptophan metabolism. Further details were shown in Table [5](#T5){ref-type="table"}. The most significant difference term was "p53 signaling pathway" (KEGG ID: hsa04115, p: 0.001), which involved 9 target genes and the network (Figure [3C](#F3){ref-type="fig"}).

###### Top 10 KEGG pathways

  Term                                          ID         Sample number   Background number   *P*-value
  --------------------------------------------- ---------- --------------- ------------------- -----------
  p53 signaling pathway                         hsa04115   9               68                  0.001
  Apoptosis                                     hsa04210   9               86                  0.005
  Lysosome                                      hsa04142   11              122                 0.006
  Metabolic pathways                            hsa01100   56              1181                0.018
  FoxO signaling pathway                        hsa04068   10              133                 0.025
  Mucin type O-Glycan biosynthesis              hsa00512   4               31                  0.030
  Amino sugar and nucleotide sugar metabolism   hsa00520   5               47                  0.031
  Endocytosis                                   hsa04144   13              203                 0.034
  Sulfur metabolism                             hsa00920   2               10                  0.061
  Tryptophan metabolism                         hsa00380   4               40                  0.062

"Term": pathway function; "ID": pathway ID; "Sample number": the number of candidate genes; "Background number": the number of background genes in the pathway; "*P* value": significance level.

Construction of lncRNAs-proteins co-expression network {#s2_4}
------------------------------------------------------

We then evaluated the co-expression network of lncRNAs and their target genes based on the criterion of combined score \> 0.9. In this co-expression network, the co-expression of lncRNA-gene and gene-gene was showed by lines of different colors (Figure [4](#F4){ref-type="fig"}). The lncRNA-gene pair with the highest positive correlation coefficient (0.993) was CYP51A1 and SC5D. These results indicated that one lncRNA closely correlated with several genes, and vice versa. The network can indicate functional relatedness or regulatory relationships \[[@R13]\].

![Construction of lncRNAs-proteins co-expression network\
The blue oval represented gene, and the red rectangle represented lncRNA. The pink lines link gene to lncRNA, green lines link gene to gene.](oncotarget-08-69995-g004){#F4}

Validation of diagnostic and prognostic value of lncRNAs in CCA {#s2_5}
---------------------------------------------------------------

We detected exosomes of differentially expressed lncRNAs between bile specimens of CCA and the control patients. Significant different expression lncRNAs: ENST00000588480.1 and ENST00000517758.1 were selected for further detection using real-time RT-PCR in bile samples of CCA (n=35) and the control patients (n=56) (Figure [5A](#F5){ref-type="fig"}). These results were higher than those shown in the expression RNA-Seq data sets. To confirm the performance of the two lncRNAs in diagnosing CCA, the receiver operating characteristic curves (ROC) were applied and the AUC of each curve was calculated (Figure [5B](#F5){ref-type="fig"}). The result indicates that the diagnosis of CCA is more efficient in the combination of the two lncRNAs than any single ones. Furthermore, the levels of ENST00000588480.1 and ENST00000517758.1 showed a significantly increasing trend with the advancement of cancer TNM stages, Figure [5C](#F5){ref-type="fig"}). The relationships of the two lncRNAs with prognosis status of CCA patients were further examined by Kaplan-Meier curve analysis and log-rank test (Figure [5D](#F5){ref-type="fig"}).

![Validation of diagnostic and prognosis value of lncRNAs in CCA\
**(A)** Different expression of ENST00000588480.1 and ENST00000517758.1, the two lncRNAs were up-regulated in CCA group (*p* = 0.036 and 0.037). **(B)** ROC curve of lncRNAs and CA19-9. The analysis showed the AUC of CA19-9 was 0.729 (95% CI, 0.620 - 0.837, it had a sensitivity and specificity of 74.3% and 71.4%; AUC of ENST00000588480.1 was 0.680 (95% CI, 0.565 - 0.796), it had a sensitivity and specificity of 62.9% and 73.2%; When ENST00000588480.1 and ENST00000517758.1 were combined, They got greater sensitivity (82.9%) (AUC: 0.709; 95% CI, 0.601-0.817). **(C)** The levels of ENST00000588480.1 and ENST00000517758.1 showed a significant increacing trend with the advancement of cancer TNM stages. (*p* = 0.039 and 0.048). **(D)** Kaplan-Meier survival overall survival (OS) curves for ENST00000588480.1 and ENST00000517758.1, The ENST00000588480.1 demonstrated statistically significant median overall survival differences (38 vs 25 months, *p* = 0.046) compared to ENST00000517758.1 (38 vs 20 months, *p* = 0.043).](oncotarget-08-69995-g005){#F5}

LncRNA signature-associated signalling pathways {#s2_6}
-----------------------------------------------

A gene KEGG pathway and Go analysis was performed according to the meterial and methods section. 479 target genes were concerned to form a gene list, while 17 of them were enriched in 3 pathways: "P53 signaling pathway", "apoptosis" and ENST00000588480.1 and ENST00000517758.1. A chart was drown to explore the associated genes and pathways of the three lncRNAs for further mechanism study (Figure [6](#F6){ref-type="fig"}). The major biological functions closely associated were apoptosis, angiogenesis, invasion and metastasis etc.

![LncRNA signature-associated signalling pathways\
A schematic diagram showed the major biological functions closely associated to were apoptosis, angiogenesis, invasion and metastasis etc.](oncotarget-08-69995-g006){#F6}

DISCUSSION {#s3}
==========

Exosomes, endosome-derived membrane microvesicles, contain specific RNA transcripts that are thought to be involved in cell-cell communication \[[@R14]\]. Exosomes in body fluids are relatively stable because of the protection of the lipid bilayer, the cargos they contain have great potential as disease biomarkers \[[@R15], [@R16]\]. It was reported that plasma lncRNA protected by exosomes as a potential stable biomarker for gastriccancer \[[@R17]\]. In urine samples, exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease \[[@R18]\]. Exosomal lncRNAs may also be potential biomarkers for predicting diseases \[[@R18], [@R19]\]. Besides, they can activate or regulate cell activities such as protein expression, cell proliferation and differentiation or antiviral responses \[[@R20]\]. Therefore, in the current study, we isolated exosomes from human bile samples for RNA-seq. Differently expressed lncRNAs were identified using qPCR method. Ultimately, three lncRNAs closely associated with CCA were selected and both diagnostic and prognostic values were examined. Combined group (ENST00000588480.1 and ENST00000517758.1) got greater sensitivity than carbohydrate antigen 19-9 (CA19-9) (82.9% vs 74.3%). We proposed that the diagnostic ability of the two lncRNAs is robust because of independent cohort of 35 CCA patients. To our knowledge, this is the first study to give a comprehensive overview of the lncRNA transcriptome changes in CCA and biliary obstruction of bile exosomes. They showed a significant increasing trend with the advancement of cancer TNM stages. Regarding prognosis, Kaplan-Meier curve analysis the higher expression group were negative correlate with the survival time. Therefore, lncRNAs can be used as a predictor to monitor the CCA.

LncRNAs were detected in exosomes of body fluid, and they were enriched in exosomes than cells \[[@R16]\], and of high tissue specificity \[[@R21]\]. The function of diagnosis potential were sufficiently reported in cancers \[[@R22]--[@R25]\]. Except for that, numerous studies have shown that lncRNAs have the function of regulate gene expression at different levels including chromatin modifications, transcription, splicing, translation, posttranscriptional regulation, processing of small RNAs, etc \[[@R26]\]. It was reported that it play active roles in various biological behaviors of tumor cells such as migration, genomic stability, immune modulation and drug resistance. For instance, Lung cancer exosomes initiate lncRNA changes in mesenchymal stem cells, lncRNAs may be involved in exosome-mediated crosstalk between MSCs and tumor cells \[[@R27]\]. exosomes containing H19 lncRNA OF cancer stem-cell-like (CSC) liver cancer cells can influence their tumor microenvironment by promoting angiogenesis \[[@R28]\]. Extracellular Vesicle lincRNA-VLDLR was relevant to the chemoresistance in hepatocellular carcinoma \[[@R29]\]. So here, we further determined the potential functions mediated by the changed lncRNAs in CCA bile exosomes.

GO and KEEG pathway analyses showed that many important functional pathways were closely related to the altered genes. Further analysis showed that the pathways involved were mainly related to cellular processes, environmental information processing as well as genetic information processing. These results emphasized the important role of micro-environmental information processing on the cellular function. Constant with the previous studies supported that lncRNAs in the tumor inflammation \[[@R30]\] or hypoxic microenvironment \[[@R31]\] may resulting in an imbalance of internal environment, which enhancing the progression of cancer progression. Although part of the variability in lncRNA repertoire size may be biologically meaningful, much is likely to be explained by unequal sequencing depth and by variable genome sequence and assembly quality.

Because the two lncRNAs were differently expressed not only between CCA and contol bile samples, but also between well- and poor prognosis patients, we speculated that these lncRNAs may play critical roles in both tumourigenesis and the progression of CCA, and that both of the two lncRNAs may be potential therapeutic targets in CCA. To preliminarily reveal the potential functions of the lncRNAs in CCA, the mRNAs co-expressed with each of the three lncRNAs were used to conduct KEGG and GO analysis in KOBAS, the website is <http://kobas.cbi.pku.edu.cn/index.php>. ENST00000588480.1 enriches the Hedgehog signaling pathway, and may have the function of 'lipid biosynthetic process', 'Wnt signaling pathway', "binding of glycoprotein, ribosomal protein and phosphoprotein", "peptide kinase and phosphotransferase activity". ENST00000517758.1 enriches "p53 signaling pathway", "Pathways in cancer" and "Endocytosis" etc. and may have the function of "Metal ion binding", "regulation of leukocyte and T cell apoptotic process", "cholesterol metabolism" and "transmembrane transporter activity". These informations may improve the current understanding of the close association between the two lncRNAs and CCA, but the underlying mechanism has not been deciphered. Additional prospective and multicentre studies with a considerable pool of patients are needed to determine whether this signature is applicable for CCA.

MATERIALS AND METHODS {#s4}
=====================

Patient samples and bile exosome isolation {#s4_1}
------------------------------------------

Bile samples of CCA (n = 35, [Supplementary Table 1](#SD1){ref-type="supplementary-material"}) and biliary obstruction patients (n = 56) were obtained by endoscopic retrograde cholangiopancreatography (ERCP) or surgery from the second affiliated hospital of Nanjing Medical University, aspiration of bile was performed after cannulation of the biliary tree before injection of contrast. All work presented here was approved by second affiliated hospital of Nanjing Medical University Review Board. All patients provided written informed consent. We prepared about 4ml of bile samples for use, They were centrifuged at 500g for 10 minutes at 4°C to pellet cells and debris. The supernatant was then centrifuged at 16500g for 20 minutes at 4°C to further remove cellular debris and then filtered through a 200-nm filter. Then Pipet the filtered supernatant to ultracentrifuge tubes and add PBS so that the tubes are more than 2/3 full, ultracentrifugate at 120000 g for 70 min at 4°C, then we can get small yellow pellets at the bottom of the ultracentrifuge tube. Exosomes were utilized for immediate RNA sequencing, RNA extraction or resuspended in phosphate buffered saline and stored in -80°C.

Functional assays {#s4_2}
-----------------

Please see the [SUPPLEMENTARY MATERIALS AND METHODS](#SD1){ref-type="supplementary-material"} section.

Statistical analysis {#s4_3}
--------------------

All the biological specimens were analysed retrospectively. Data were presented as the min to max. Statistical analyses were performed using Graph pad 6.0 and/or IBM SPSS Statistics 17.0 software, differences were considered statistically significant when the p \< 0.05. The difference between CCA and control group was analyzed using a Mann-Whitney test. Then CCA patients were divided into high and low groups according to the median of the lncRNA expression, survival curves were estimated using the Kaplan-Meier method, and differences in survival distributions were evaluated by the log-rank test.
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